实体器官移植史患者择期切口疝修补术后住院时间与手术部位并发症未增加
本研究基于ACHQC前瞻性收集数据的回顾性分析,比较有与无实体器官移植史的择期切口疝修补患者。调整混杂因素后,移植史患者的中位住院时间与无移植史者无显著差异,30天手术部位感染、需干预的手术部位事件及复发率亦相似。结论提示移植史不应成为择期切口疝修补的禁忌。
要点
- 移植史患者择期切口疝修补术后中位住院时间与无移植史者无显著差异。
- 移植史患者30天手术部位感染、需干预事件及复发率与无移植史者相似。
- 尽管移植史患者存在免疫抑制等危险因素,不应据此排除择期切口疝修补手术。
核心结论
- 有实体器官移植史的患者行择期切口疝修补术后住院时间和手术部位感染率与无移植史者无显著差异。
- 因此,移植史不应成为择期切口疝修补手术的禁忌。
研究设计与样本
- 基于ACHQC前瞻性收集数据的回顾性研究,纳入18岁及以上行择期切口疝修补的患者。
- 共分析13,452例(98.79%)无移植史患者和165例(1.21%)有实体器官移植史患者。
主要发现
- 移植史组与无移植史组的SSI发生率分别为2.4%和4.04%(p=0.42),SSOPI发生率分别为4.2%和5.8%(p=0.38),复发率分别为0.6%和0.4%(p=0.51)。
- 其他30天术后并发症在样本中可忽略。
临床怎么用
- 对于有实体器官移植史且需行择期切口疝修补的患者,不应仅因移植史而拒绝手术。
- 术前应充分评估免疫抑制和慢性激素使用等危险因素,但移植史本身不预示住院时间延长或手术部位并发症增加。
局限性
- 本研究为回顾性分析,可能存在选择偏倚和残余混杂。
- 移植史患者样本量较小(165例),可能影响统计效能。
- 其他30天术后并发症在样本中可忽略,未能充分评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The incidence of ventral hernia development after solid organ transplantation has been reported to be up to 30%. We aim to determine the impact of previous solid organ transplant on post-operative length of stay (LOS) and surgical site complications in elective ventral hernia repairs. METHODS: A retrospective review of prospectively collected data from the Abdominal Core Health Quality Collaborative (ACHQC) was conducted to include all patients age 18 years or older who underwent elective incisional hernia repair. Those with and without a history of solid organ transplantation were compared. The primary outcome was in-hospital LOS. Secondary outcomes included 30-day surgical site infection (SSI) rate, 30-day surgical site occurrence requiring procedural intervention (SSOPI) rate, 30-day overall post-operative complications and recurrence. The association between transplant and the LOS was tested with a negative binomial regression model adjusted for the demographic characteristics, comorbidities and hernia characteristics in the model. RESULTS: The population analyzed included 13,452 (98.79%) patients without a history of organ transplantation and 165 (1.21%) patients who had a history of organ transplantation. After adjusting for age, hernia width, BMI, gender, race, insurance type, ASA class, hypertension, dyspnea, OR time > 2 h, abdominal wall SSI history, recurrent hernia, operative approach the median LOS was not significantly different between patients with a history of solid organ transplant [2.8 (2.6, 2.9) days] and those without [2.6 days (2.2, 3.1)] (p = 0.5). The proportion of SSI (2.4% vs 4.04%; p = 0.42), SSOPI (4.2% vs 5.8%; p = 0.38) and recurrence (0.6% vs 0.4%, p = 0.51) was similar between both groups. Other remaining 30-day post-operative were negligible in our sample. CONCLUSIONS: There were no significant differences in LOS or infection rates between patients with and without a history of solid organ transplantation despite known risks of immunosuppression and chronic steroid use. Therefore, although these patients have many classic risk factors for poor outcomes, the data suggest that their history of solid organ transplantation should not preclude them from surgery.
引用
- Woelfel I, Gupta A, Renshaw S, et al. Length of stay and surgical site complications are not increased after elective incisional hernia in patients with a history of solid organ transplantation. Surg Endosc. 2021. PMID: 33788030. doi:10.1007/s00464-021-08458-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。